gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with pentetic acid in 43 studies
Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (pentetic acid) | Trials (pentetic acid) | Recent Studies (post-2010) (pentetic acid) |
---|---|---|---|---|---|
638 | 31 | 243 | 7,774 | 301 | 587 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (32.56) | 18.7374 |
1990's | 28 (65.12) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (2.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, RD; Brucher, E; Geraldes, CF; Koenig, SH; Sherry, AD; Spiller, M | 1 |
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
Kumar, K; Tweedle, MF; Wedeking, P | 2 |
Doyon, DL; Halimi, PM; Lhuillier, FM; Sigal, RC; Sterkers, JM | 1 |
Ekholm, SE; Morris, TW; Prentice, LI | 1 |
Ekholm, SE; Leakey, P; Marinetti, GV; Morris, TW; Prentice, LI | 1 |
Koenig, SH | 2 |
Paajanen, H | 1 |
Gelblum, DY; Jacobson, S; Runge, VM | 1 |
Doucet, D; Meyer, D; Schaefer, M | 1 |
Gries, H; Press, WR; Weinmann, HJ | 1 |
Ahkong, QF; Fritz, T; Tilcock, C; Unger, E | 1 |
Lex, L | 1 |
Stark, DD; Weissleder, R | 1 |
Adelman, LS; Jacobson, S; Kaufman, DM; Runge, VM; Wood, ML | 1 |
Allard, M; Bonnemain, B; Caillé, JM; Meyer, D; Simonnet, G | 1 |
Allard, M; Bonnemain, B; Caille, JM; Kien, P; Simonnet, G | 1 |
Fischer, H; Maton, F; Muller, RN; Rinck, PA; Roch, A; Vallet, P; Van Haverbeke, Y; Vander Elst, L | 1 |
Amiel, M; Baguet, J; Belleville, J; Corot, C; Eloy, R; Paul, J | 1 |
Allard, M; Bonnemain, B; Caillé, JM; Doucet, D; Kien, P | 1 |
Tweedle, M; Wedeking, P | 1 |
Bousquet, JC; Ferrucci, JT; Hahn, PF; Nigam, M; Saini, S; Stark, DD; Wittenberg, J | 1 |
Bennett, HF; Brasch, RC | 1 |
Belleville, J; Corot, C; Eloy, R; Paul, J | 1 |
Adelman, LS; Jacobson, S; Kaufman, D; Runge, VM; Wood, ML | 1 |
Baltzer, L; Brechbiel, MW; Colcher, D; Gansow, OA; Girton, ME; Knop, RH; Magerstädt, M; Naegele, M | 1 |
Dommisse, R; Lanens, D; Oksendal, A; Spanoghe, M; Van Audekerke, J; Van der Linden, A | 1 |
Corot, C; Curtelin, L; Hentsch, AM | 1 |
Derugin, N; Higgins, CB; Lauerma, K; Roberts, TP; Saeed, M; Varadarajan, J; Watson, AD; Wendland, MF; Yu, KK | 1 |
Berry, I; Brugières, P; de Schepper, AM; Degryse, HR; Gaston, A; Le Bras, F; Manelfe, C; Marsault, C; Parizel, PM; Wichmann, W | 1 |
Beaufils, H; Bourbouze, R; Brillet, G; Deray, G; Dubois, M | 1 |
Goudemant, JF; Muller, RN; Van Haverbeke, Y; Vander Elst, L | 1 |
Balériaux, D; De Greef, D; Matos, C | 1 |
Abs, R; Mahler, C; Martin, JJ; Parizel, PM; Van de Kelft, E; Van Marck, E; Verhelst, J; Verlooy, J; Willems, PJ | 1 |
De Schepper, AM; Delaporte, C; Forton, GE; Martin, JJ; Mulkens, TH; Parizel, PM; van de Heyning, PH | 1 |
Debatin, JF; Huch Böni, RA; Krestin, GP | 1 |
Benderbous, S; Clément, O; Cuénod, CA; Frija, G; Siauve, N | 1 |
Kellar, KE; Koenig, SH | 1 |
Nowak, PJ; Oudkerk, M; Sijens, PE; van den Bent, MJ; van Dijk, P | 1 |
Belford, RL; Clarkson, RB; Smirnov, AI; Smirnova, TI | 1 |
Bernardo, M; Brechbiel, MW; Nwe, K; Regino, CA; Williams, M | 1 |
6 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and pentetic acid
Article | Year |
---|---|
Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1990 |
Early experience of paramagnetic tracers in ultra low magnetic fields.
Topics: Animals; Contrast Media; Fibrinogen; Gadolinium DTPA; Heterocyclic Compounds; Immunoglobulin G; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rabbits; Serum Albumin, Bovine; Swine | 1990 |
Development of contrast enhancing agents in magnetic resonance imaging.
Topics: Animals; Antibodies; Contrast Media; Ferric Compounds; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liposomes; Magnetic Resonance Imaging; Nitrogen Oxides; Organometallic Compounds; Pentetic Acid; Porphyrins | 1989 |
Magnetic resonance imaging of liver tumors.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1989 |
Contrast-enhanced MR imaging of the kidneys and adrenal glands.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1996 |
Interaction of Gd(III) MRI contrast agents with membranes: a review of recent EPR studies.
Topics: Chelating Agents; Electromagnetic Fields; Electron Spin Resonance Spectroscopy; Gadolinium; Heterocyclic Compounds; Magnetic Resonance Imaging; Membrane Lipids; Organometallic Compounds; Pentetic Acid; Spectrophotometry; Spin Labels; Temperature | 1999 |
2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and pentetic acid
Article | Year |
---|---|
Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1994 |
Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.
Topics: Brain; Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Spinal Cord; Spinal Cord Neoplasms | 1993 |
35 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and pentetic acid
Article | Year |
---|---|
Nuclear magnetic relaxation dispersion profiles of aqueous solutions of a series of Gd(NOTA) analogs.
Topics: Aza Compounds; Chelating Agents; Contrast Media; Edetic Acid; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphorus Compounds; Pentetic Acid; Structure-Activity Relationship | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Dissociation of gadolinium chelates in mice: relationship to chemical characteristics.
Topics: Animals; Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1992 |
Magnetic resonance imaging of acoustic neuromas: pitfalls and differential diagnosis.
Topics: Contrast Media; Diagnosis, Differential; Ear, Inner; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neurofibromatosis 2; Neuroma, Acoustic; Organometallic Compounds; Pentetic Acid | 1992 |
The effects of gadolinium-DTPA and -DOTA on neural tissue metabolism.
Topics: Animals; Carbon Dioxide; Contrast Media; Dose-Response Relationship, Drug; Gadolinium DTPA; Glucose; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Organometallic Compounds; Pentetic Acid; Rabbits; Rats; Rats, Inbred Strains | 1991 |
Gd-DTPA and Gd-DOTA effects on metabolism of glucose and phosphatidylinositols.
Topics: Animals; Brain; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Glucose; Heterocyclic Compounds; Hippocampus; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Phosphatidylinositols; Rats; Rats, Inbred Strains; Synaptosomes | 1991 |
Gd HP-DO3A--experimental evaluation in brain and renal MR.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Models, Structural; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Time Factors | 1991 |
Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents.
Topics: Albumins; Animals; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
Tolerance of extracellular contrast agents for magnetic resonance imaging.
Topics: Animals; Contrast Media; Drug Combinations; Drug Tolerance; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Mice; Organometallic Compounds; Osmolar Concentration; Pentetic Acid; Rats | 1990 |
Paramagnetic liposomes as magnetic resonance contrast agents.
Topics: Animals; Drug Carriers; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Liposomes; Magnetic Resonance Imaging; Male; Mice; Organometallic Compounds; Pentetic Acid; Rats | 1990 |
Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Kidney Medulla; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344 | 1989 |
Action of gadolinium complexes on different enzyme systems.
Topics: Animals; Brain; Choline O-Acetyltransferase; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Glutamate Decarboxylase; Heterocyclic Compounds; In Vitro Techniques; Organometallic Compounds; Pentetic Acid; Rats | 1986 |
Brain distribution of MRI contrast media in rats after intracisternal injection.
Topics: Animals; Brain; Cisterna Magna; Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1987 |
The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
In vitro interactions of gadolinium DOTA meglumine and gadolinium DTPA meglumine on hemostasis.
Topics: Contrast Media; Gadolinium DTPA; Hemostasis; Heterocyclic Compounds; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1988 |
Experimental study of DOTA-gadolinium. Pharmacokinetics and pharmacologic properties.
Topics: Animals; Contrast Media; Drug Tolerance; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1988 |
Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
Topics: Acetates; Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Male; Mice; Organometallic Compounds; Pentetic Acid; Tissue Distribution | 1988 |
Gd-DOTA: characterization of a new paramagnetic complex.
Topics: Animals; Chemical Phenomena; Chemistry; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetics; Mice; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Considerations in the choice of contrast media for MR imaging.
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1988 |
[In vitro study of the action of DOTA and DTPA-gadolinium complexes on platelet functions: aggregation and calcium excretion].
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Calcium; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; In Vitro Techniques; Male; Organometallic Compounds; Pentetic Acid; Platelet Aggregation | 1988 |
MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
Topics: Animals; Brain Neoplasms; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |
Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid; Spectrum Analysis | 1986 |
Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Topics: Animals; Calcium; Chelating Agents; Contrast Media; Excipients; Femur; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections, Intravenous; Liver; Male; Mice; Organometallic Compounds; Pentetic Acid; Radioisotopes; Rats; Time Factors; Tissue Distribution | 1995 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dysprosium; Gadolinium; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar; Time Factors | 1995 |
The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes.
Topics: Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Magnetics; Organometallic Compounds; Pentetic Acid; Water | 1994 |
Interaction of gadolinium complexes with metal-dependent biological systems.
Topics: Cell Division; Cells, Cultured; Chlorides; Contrast Media; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid; Peptidyl-Dipeptidase A; Zinc Compounds | 1994 |
Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement.
Topics: Albumins; Animals; Body Water; Contrast Media; Dose-Response Relationship, Drug; Echo-Planar Imaging; Female; Gadolinium; Gadolinium DTPA; Half-Life; Heart Ventricles; Heterocyclic Compounds; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Myocardium; Organometallic Compounds; Pentetic Acid; Polylysine; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
Topics: Acute Kidney Injury; Animals; Contrast Media; Diatrizoate; Gadolinium DTPA; Heterocyclic Compounds; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
Topics: Contrast Media; Drug Stability; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Organometallic Compounds; Pentetic Acid | 1994 |
The association of meningioma and pituitary adenoma: report of seven cases and review of the literature.
Topics: Adenoma; Adrenocorticotropic Hormone; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium DTPA; Growth Hormone; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meninges; Meningioma; Middle Aged; Neoplasms, Multiple Primary; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1993 |
MRI of acoustic schwannoma: a retrospective study of 89 tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroma, Acoustic; Organometallic Compounds; Pentetic Acid; Retrospective Studies | 1993 |
Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
Topics: Animals; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Heterocyclic Compounds; Liver; Lymph; Macromolecular Substances; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Rabbits | 1996 |
Theory of proton relaxation in solutions of magnetic nanoparticles, including the superparamagnetic size range.
Topics: Animals; Contrast Media; Ferrosoferric Oxide; Gadolinium DTPA; Heterocyclic Compounds; Humans; Iron; Magnetic Resonance Imaging; Models, Theoretical; Organometallic Compounds; Oxides; Particle Size; Pentetic Acid | 1996 |
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Fourier Analysis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Regression Analysis | 1997 |
Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
Topics: Animals; Contrast Media; Dendrimers; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Mice, Nude; Organometallic Compounds; Pentetic Acid | 2010 |